144 related articles for article (PubMed ID: 23255905)
1. Second-line chemotherapy for refractory small cell neuroendocrine carcinoma of the esophagus that relapsed after complete remission with irinotecan plus cisplatin therapy: Case report and review of the literature.
Funakoshi S; Hashiguchi A; Teramoto K; Miyata N; Kurita S; Adachi M; Hamamoto Y; Higuchi H; Takaishi H; Hibi T
Oncol Lett; 2013 Jan; 5(1):117-122. PubMed ID: 23255905
[TBL] [Abstract][Full Text] [Related]
2. Are levels of pro-gastrin-releasing peptide or neuron-specific enolase at relapse prognostic factors after relapse in patients with small-cell lung cancer?
Hirose T; Okuda K; Yamaoka T; Ishida K; Kusumoto S; Sugiyama T; Shirai T; Ohnshi T; Ohmori T; Adachi M
Lung Cancer; 2011 Feb; 71(2):224-8. PubMed ID: 20537424
[TBL] [Abstract][Full Text] [Related]
3. [Utility of NSE, ProGRP and LDH in Diagnosis and Treatment
in Patients with Small Cell Lung Cancer].
Peng Y; Wang Y; Li J; Hao X; Hu X
Zhongguo Fei Ai Za Zhi; 2016 Sep; 19(9):590-4. PubMed ID: 27666548
[TBL] [Abstract][Full Text] [Related]
4. ProGRP and NSE in therapy monitoring in patients with small cell lung cancer.
Wójcik E; Kulpa JK; Sas-Korczyńska B; Korzeniowski S; Jakubowicz J
Anticancer Res; 2008; 28(5B):3027-33. PubMed ID: 19031951
[TBL] [Abstract][Full Text] [Related]
5. Complete response of esophageal small cell carcinoma amrubicin treatment.
Nagasaki E; Yuda M; Tanishima Y; Arakawa Y; Kobayashi K; Sakuyama T; Inoue D; Nishikawa K; Kobayashi M; Omura N; Kobayashi T; Aiba K
J Infect Chemother; 2013 Aug; 19(4):770-5. PubMed ID: 23160626
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of circulating neuroendocrine markers chromogranin a, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer.
Nisman B; Heching N; Biran H; Barak V; Peretz T
Tumour Biol; 2006; 27(1):8-16. PubMed ID: 16340245
[TBL] [Abstract][Full Text] [Related]
7. Pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in therapy control of patients with small-cell lung cancer.
Schneider J; Philipp M; Salewski L; Velcovsky HG
Clin Lab; 2003; 49(1-2):35-42. PubMed ID: 12593474
[TBL] [Abstract][Full Text] [Related]
8. Pro-gastrin-releasing peptide and neuron-specific enolase: useful predictors of response to chemotherapy and survival in patients with small cell lung cancer.
Huang Z; Xu D; Zhang F; Ying Y; Song L
Clin Transl Oncol; 2016 Oct; 18(10):1019-25. PubMed ID: 26886220
[TBL] [Abstract][Full Text] [Related]
9. Combined chemotherapy with carboplatin plus irinotecan showed favorable efficacy in a patient with relapsed small cell carcinoma of the prostate complicated with meningeal carcinomatosis.
Yamada T; Ohtsubo K; Mouri H; Yamashita K; Yasumoto K; Izumi K; Zen Y; Watanabe H; Yano S
Int J Clin Oncol; 2009 Oct; 14(5):468-72. PubMed ID: 19856060
[TBL] [Abstract][Full Text] [Related]
10. Primary small cell carcinoma of the esophagus with achalasia in a patient in whom pro-gastrin-releasing peptide and neuron-specific enolase levels reflected the clinical course during chemotherapy.
Suzuki H; Takayanagi S; Otake T; Ishibashi R; Osawa S; Shirai T; Takashima M; Hanai H; Kaneko E
J Gastroenterol; 1999 Jun; 34(3):378-82. PubMed ID: 10433016
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Amrubicin and Weekly Cisplatin/Etoposide/Irinotecan in Patients With Relapsed Small-cell Lung Cancer.
Okuma HS; Horinouchi H; Kitahara S; Asao T; Sunami K; Goto Y; Kanda S; Fujiwara Y; Nokihara H; Yamamoto N; Ohe Y
Clin Lung Cancer; 2017 Mar; 18(2):234-240.e2. PubMed ID: 27867001
[TBL] [Abstract][Full Text] [Related]
12. Small cell carcinoma of the esophagus: report of a case with review of the literature.
Alici S; Ozen S; Kotan C
J BUON; 2002; 7(2):161-4. PubMed ID: 17577283
[TBL] [Abstract][Full Text] [Related]
13. Effective monotherapy with amrubicin for a refractory extrapulmonary small-cell carcinoma of the liver.
Isobe T; Yanai S; Kusaba H; Yada S; Kuroda Y; Tamiya S; Matsumoto T; Baba E; Harada M
Case Rep Med; 2009; 2009():538081. PubMed ID: 19718248
[TBL] [Abstract][Full Text] [Related]
14. Combined chemotherapy with cisplatin, etoposide, and irinotecan versus topotecan alone as second-line treatment for patients with sensitive relapsed small-cell lung cancer (JCOG0605): a multicentre, open-label, randomised phase 3 trial.
Goto K; Ohe Y; Shibata T; Seto T; Takahashi T; Nakagawa K; Tanaka H; Takeda K; Nishio M; Mori K; Satouchi M; Hida T; Yoshimura N; Kozuki T; Imamura F; Kiura K; Okamoto H; Sawa T; Tamura T;
Lancet Oncol; 2016 Aug; 17(8):1147-1157. PubMed ID: 27312053
[TBL] [Abstract][Full Text] [Related]
15. Collision Carcinoma Involving Small Cell Neuroendocrine Carcinoma and Squamous Cell Carcinoma of the Ureter: A Case Report and Review of the Literature.
Xu S; Xu L; Cao P; Yao S; Wu T; Hu X; Chen H; Gu J; Che X
Front Oncol; 2021; 11():663119. PubMed ID: 34290980
[TBL] [Abstract][Full Text] [Related]
16. Amrubicin is effective against small cell carcinoma of the prostate as a second-line chemotherapeutic agent: A case report.
Maesaka F; Nakai Y; Tomizawa M; Owari T; Miyake M; Inoue T; Anai S; Tanaka N; Fujimoto K
IJU Case Rep; 2019 May; 2(3):133-136. PubMed ID: 32743393
[TBL] [Abstract][Full Text] [Related]
17. Small cell carcinoma of the esophagus responding to fourth-line chemotherapy with weekly paclitaxel.
Matsuoka M; Boku N; Yoshino T; Hironaka S; Onozawa Y; Fukutomi A; Zenda S; Yamazaki K; Yasui H; Hasuike N; Inui T; Yamaguchi Y; Ono H; Kamata M
Int J Clin Oncol; 2005 Dec; 10(6):429-32. PubMed ID: 16369748
[TBL] [Abstract][Full Text] [Related]
18. A case of esophageal small cell carcinoma with multiple liver metastases responding to chemotherapy with irinotecan plus cisplatin.
Endo K; Kohnoe S; Toh Y; Haraguchi M; Nishiyama K; Okamura T; Baba H; Maehara Y
J Exp Clin Cancer Res; 2005 Dec; 24(4):647-50. PubMed ID: 16471329
[TBL] [Abstract][Full Text] [Related]
19. Complementary roles of pro-gastrin-releasing peptide (ProGRP) and neuron specific enolase (NSE) in diagnosis and prognosis of small-cell lung cancer (SCLC).
Shibayama T; Ueoka H; Nishii K; Kiura K; Tabata M; Miyatake K; Kitajima T; Harada M
Lung Cancer; 2001 Apr; 32(1):61-9. PubMed ID: 11282430
[TBL] [Abstract][Full Text] [Related]
20. A retrospective study of definitive chemoradiotherapy in patients with resectable small cell neuroendocrine carcinoma of the esophagus.
Katada C; Komori S; Yoshida T; Kawakami S; Watanabe A; Ishido K; Azuma M; Wada T; Hosoda K; Yamashita K; Hiki N; Tanabe S; Ishiyama H; Koizumi W
Esophagus; 2020 Apr; 17(2):135-140. PubMed ID: 31321580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
